Significant Heterogeneity in Parameter Assumptions in Cost-Effectiveness Analyses in Prostate Adenocarcinoma: A Systematic Review

被引：1
|
作者：
Butala, A. A. [1 ]
Bryant, C. M. [2 ]
Nichols, R. C., Jr. [2 ]
Henderson, R. H. [2 ]
Hoppe, B. S. [2 ]
Mendenhall, N. P. [2 ]
Vapiwala, N. [1 ]
Vega, R. Mailhot [2 ]
机构：
[1] Univ Penn, Dept Radiat Oncol, Philadelphia, PA 19104 USA
[2] Univ Florida, Coll Med, Dept Radiat Oncol, Gainesville, FL USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2019年 / 105卷 / 01期
关键词：
D O I：
10.1016/j.ijrobp.2019.06.224
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1144
引用
收藏
页码：S181 / S182
页数：2
相关论文
共 50 条
  • [1] Heterogeneity in Radiotherapeutic Parameter Assumptions in Cost-Effectiveness Analyses in Prostate Cancer: A Call for Uniformity
    Butala, Anish A.
    Huang, Christina C.
    Bryant, Curtis M.
    Henderson, Randal H.
    Hoppe, Bradford S.
    Mendenhall, Nancy P.
    Vapiwala, Neha
    Vega, Raymond B. Mailhot
    [J]. VALUE IN HEALTH, 2022, 25 (02) : 171 - 177
  • [2] Cost-effectiveness analyses and cost analyses in castration-resistant prostate cancer: A systematic review
    Grochtdreis, Thomas
    Koenig, Hans-Helmut
    Dobruschkin, Alexander
    von Amsberg, Gunhild
    Dams, Judith
    [J]. PLOS ONE, 2018, 13 (12):
  • [3] Clarifying Assumptions and Outcomes in Cost-effectiveness Analyses
    ten Haaf, Kevin
    de Koning, Harry J.
    [J]. JAMA ONCOLOGY, 2016, 2 (02) : 277 - 278
  • [4] A systematic review of cost-effectiveness analyses of pharmacogenomic interventions
    Phillips, KA
    Van Bebber, SL
    [J]. PHARMACOGENOMICS, 2004, 5 (08) : 1139 - 1149
  • [5] Systematic Review of Cost-Effectiveness Analyses of Treatments for Psoriasis
    Zhang, Wei
    Islam, Nazrul
    Ma, Canice
    Anis, Aslam H.
    [J]. PHARMACOECONOMICS, 2015, 33 (04) : 327 - 340
  • [6] Cost-effectiveness analyses of denosumab for osteoporosis: a systematic review
    Y. Wan
    F. Zeng
    H. Tan
    Y. Lu
    Y. Zhang
    L. Zhao
    R. You
    [J]. Osteoporosis International, 2022, 33 : 979 - 1015
  • [7] Cost-effectiveness analyses of denosumab for osteoporosis: a systematic review
    Wan, Y.
    Zeng, F.
    Tan, H.
    Lu, Y.
    Zhang, Y.
    Zhao, L.
    You, R.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2022, 33 (05) : 979 - 1015
  • [8] Cost-effectiveness Analyses of Antihypertensive Medicines: A Systematic Review
    Park, Chanhyun
    Wang, Guijing
    Durthaler, Jefferey M.
    Fang, Jing
    [J]. AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2017, 53 (06) : S131 - S142
  • [9] Systematic Review of Cost-Effectiveness Analyses of Treatments for Psoriasis
    Wei Zhang
    Nazrul Islam
    Canice Ma
    Aslam H. Anis
    [J]. PharmacoEconomics, 2015, 33 : 327 - 340
  • [10] A systematic review of cost-effectiveness analyses for the treatment of stroke
    Holloway, RG
    Benesch, C
    Courtright, CE
    Rahilly, CR
    [J]. ANNALS OF NEUROLOGY, 1998, 44 (03) : 517 - 517
12345